CELZ
Income statement / Annual
Last year (2025), Creative Medical Technology Holdings Inc's total revenue was $6.00 K,
a decrease of 45.45% from the previous year.
In 2025, Creative Medical Technology Holdings Inc's net income was -$6.00 M.
See Creative Medical Technology Holdings Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$6.00 K |
$11.00 K |
$9.00 K |
$88.60 K |
$87.75 K |
$164.50 K |
$165.50 K |
$124.40 K |
$4.80 K |
$0.00 |
| Cost of Revenue |
$125.52 K
|
$4.40 K
|
$3.60 K
|
$28.49 K
|
$47.95 K
|
$50.60 K
|
$45.50 K
|
$70.38 K
|
$8.00 K
|
$766.07 K
|
| Gross Profit |
-$119.52 K
|
$6.60 K
|
$5.40 K
|
$60.11 K
|
$39.81 K
|
$113.90 K
|
$120.00 K
|
$54.03 K
|
-$3.20 K
|
-$766.07 K
|
| Gross Profit Ratio |
-19.92
|
0.6
|
0.6
|
0.68
|
0.45
|
0.69
|
0.73
|
0.43
|
-0.67
|
0
|
| Research and Development Expenses |
$2.26 M
|
$2.40 M
|
$1.97 M
|
$6.27 M
|
$109.18 K
|
$0.00
|
$0.00
|
$96.62 K
|
$260.09 K
|
$85.33 K
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.22 M
|
$1.05 M
|
$898.53 K
|
$664.98 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.76 M
|
$3.24 M
|
$3.56 M
|
$3.94 M
|
$2.96 M
|
$1.16 M
|
$1.22 M
|
$1.05 M
|
$898.53 K
|
$664.98 K
|
| Other Expenses |
$0.00
|
$110.45 K
|
$94.58 K
|
$92.08 K
|
$92.08 K
|
$66.79 K
|
$26.95 K
|
$21.14 K
|
$0.00
|
$9.36 K
|
| Operating Expenses |
$6.02 M
|
$5.75 M
|
$5.63 M
|
$10.30 M
|
$3.17 M
|
$1.23 M
|
$1.25 M
|
$1.17 M
|
$1.17 M
|
$759.67 K
|
| Cost And Expenses |
$6.15 M
|
$5.75 M
|
$5.63 M
|
$10.33 M
|
$3.21 M
|
$1.28 M
|
$1.30 M
|
$1.24 M
|
$1.18 M
|
$759.67 K
|
| Interest Income |
$147.81 K
|
$250.38 K
|
$333.56 K
|
$100.33 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.28 M
|
$1.23 M
|
$1.90 M
|
$1.36 M
|
$377.59 K
|
$6.40 K
|
| Depreciation & Amortization |
$123.33 K
|
$110.45 K
|
$94.58 K
|
$92.08 K
|
$92.08 K
|
$66.79 K
|
$26.95 K
|
$21.14 K
|
$15.99 K
|
$9.36 K
|
| EBITDA |
-$6.02 M |
-$5.63 M |
-$5.53 M |
-$10.15 M |
$23.58 M |
-$35.03 M |
-$6.56 M |
-$1.09 M |
-$1.16 M |
-$750.32 K |
| EBITDA Ratio |
-1003.25
|
-512.13
|
-613.95
|
-114.59
|
268.73
|
-212.94
|
-39.64
|
-8.79
|
-242.04
|
0
|
| Operating Income Ratio |
-1023.8
|
-522.17
|
-624.46
|
-115.62
|
-35.62
|
-6.78
|
-6.83
|
-8.96
|
-245.38
|
0
|
| Total Other Income/Expenses Net |
$147.81 K
|
$250.38 K
|
$333.56 K
|
$100.33 K
|
$22.34 M
|
-$35.21 M
|
-$7.35 M
|
-$12.54 M
|
-$1.48 M
|
-$6.40 K
|
| Income Before Tax |
-$6.00 M
|
-$5.49 M
|
-$5.29 M
|
-$10.14 M
|
$19.21 M
|
-$36.33 M
|
-$8.48 M
|
-$13.66 M
|
-$2.66 M
|
-$766.07 K
|
| Income Before Tax Ratio |
-999.17
|
-499.41
|
-587.4
|
-114.49
|
218.93
|
-220.82
|
-51.26
|
-109.77
|
-553.98
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$6.00 M
|
-$5.49 M
|
-$5.29 M
|
-$10.14 M
|
$19.21 M
|
-$36.33 M
|
-$8.48 M
|
-$13.66 M
|
-$2.66 M
|
-$766.07 K
|
| Net Income Ratio |
-999.17
|
-499.41
|
-587.4
|
-114.49
|
218.93
|
-220.82
|
-51.26
|
-109.77
|
-553.98
|
0
|
| EPS |
-2.52 |
-3.71 |
-3.76 |
-9.28 |
73.75 |
-626.88 |
-5017.67 |
-11351.33 |
-17379.79 |
-5471.94 |
| EPS Diluted |
-2.52 |
-3.71 |
-3.76 |
-9.28 |
56.1 |
-626.88 |
-5017.67 |
-11351.33 |
-17379.79 |
-5471.94 |
| Weighted Average Shares Out |
$2.38 M
|
$1.48 M
|
$1.41 M
|
$1.09 M
|
$260.51 K
|
$57.95 K
|
$2.07 K
|
$1.20 K
|
$153.00
|
$140.00
|
| Weighted Average Shares Out Diluted |
$2.38 M
|
$1.48 M
|
$1.41 M
|
$1.09 M
|
$324.86 K
|
$57.95 K
|
$2.07 K
|
$1.20 K
|
$153.00
|
$140.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
